Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lucas

Showing results (1371-1380 of 1,402) with videos related to

Pageof 141
Sort By:
Cell|August 1, 2025
Ancient hybridization underlies tuberization and radiation of the potato lineageZhiyang Zhang, Pingxian Zhang, Yiyuan Ding, et al.
Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.
Journal of Pediatric Surgery|July 4, 2024
Screening and Prophylaxis for Venous Thromboembolism in Pediatric Surgery: A Systematic ReviewLorraine I Kelley-Quon, Shannon N Acker, Shawn St Peter, et al.
Science Translational Medicine|September 29, 2021
CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's diseaseSara Picó, Alberto Parras, María Santos-Galindo, et al.
Journal of Pediatric Surgery|June 24, 2024
Management and Outcomes of Pediatric Lymphatic Malformations: A Systematic Review From the APSA Outcomes and Evidence-Based Practice CommitteeCarlos Theodore Huerta, Alana L Beres, Brian R Englum, et al.
Hepatology (Baltimore, Md.)|May 10, 2023
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM studyQuentin M Anstee, Kathryn J Lucas, Sven Francque, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffoldPhilippe G Nantermet, Christopher S Burgey, Kyle A Robinson, et al.
Brain : a Journal of Neurology|October 9, 2010
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's diseaseCristina Blázquez, Anna Chiarlone, Onintza Sagredo, et al.
Journal of Medicinal Chemistry|November 7, 1998
Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templatesP E Sanderson, T A Lyle, K J Cutrona, et al.
Nature Communications|December 11, 2023
Carbonate chemistry and carbon sequestration driven by inorganic carbon outwelling from mangroves and saltmarshesGloria M S Reithmaier, Alex Cabral, Anirban Akhand, et al.
Pageof 141

Showing results (1371-1380 of 1,402) with videos related to

Sort By:
Pageof 141
Cell|August 1, 2025
Ancient hybridization underlies tuberization and radiation of the potato lineageZhiyang Zhang, Pingxian Zhang, Yiyuan Ding, et al.
Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.
Journal of Pediatric Surgery|July 4, 2024
Screening and Prophylaxis for Venous Thromboembolism in Pediatric Surgery: A Systematic ReviewLorraine I Kelley-Quon, Shannon N Acker, Shawn St Peter, et al.
Science Translational Medicine|September 29, 2021
CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's diseaseSara Picó, Alberto Parras, María Santos-Galindo, et al.
Journal of Pediatric Surgery|June 24, 2024
Management and Outcomes of Pediatric Lymphatic Malformations: A Systematic Review From the APSA Outcomes and Evidence-Based Practice CommitteeCarlos Theodore Huerta, Alana L Beres, Brian R Englum, et al.
Hepatology (Baltimore, Md.)|May 10, 2023
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM studyQuentin M Anstee, Kathryn J Lucas, Sven Francque, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffoldPhilippe G Nantermet, Christopher S Burgey, Kyle A Robinson, et al.
Brain : a Journal of Neurology|October 9, 2010
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's diseaseCristina Blázquez, Anna Chiarlone, Onintza Sagredo, et al.
Journal of Medicinal Chemistry|November 7, 1998
Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templatesP E Sanderson, T A Lyle, K J Cutrona, et al.
Nature Communications|December 11, 2023
Carbonate chemistry and carbon sequestration driven by inorganic carbon outwelling from mangroves and saltmarshesGloria M S Reithmaier, Alex Cabral, Anirban Akhand, et al.
Pageof 141